FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

RH Barbhaiya

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Drug Interactions

Phenomena

Metabolic Clearance Rate

Co-author Network

Publications

TOP 3
Nuggehally R Srinivas; RH Barbhaiya; K K Midha
Enantiomeric drug development: issues, considerations, and regulatory requirements.
Punit Marathe; M E Arnold; J Meeker; DS Greene; RH Barbhaiya
Pharmacokinetics and bioavailability of a metformin/glyburide tablet administered alone and with food.
Punit Marathe; Y Wen; J Norton; DS Greene; RH Barbhaiya; I R Wilding
Effect of altered gastric emptying and gastrointestinal motility on metformin absorption.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of RH Barbhaiya (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Nuggehally R Srinivas; RH Barbhaiya; K K Midha
Enantiomeric drug development: issues, considerations, and regulatory requirements.
Journal of pharmaceutical sciences 2001;90(9):1205-15.
2000: Punit Marathe; M E Arnold; J Meeker; DS Greene; RH Barbhaiya
Pharmacokinetics and bioavailability of a metformin/glyburide tablet administered alone and with food.
Journal of clinical pharmacology 2000;40(12 Pt 2):1494-502.
2000: Punit Marathe; Y Wen; J Norton; DS Greene; RH Barbhaiya; I R Wilding
Effect of altered gastric emptying and gastrointestinal motility on metformin absorption.
British journal of clinical pharmacology 2000;50(4):325-32.
2000: Randy C Dockens; K S Santone; James Mitroka; Richard A Morrison; M Jemal; DS Greene; RH Barbhaiya
Disposition of radiolabeled ifetroban in rats, dogs, monkeys, and humans.
Drug metabolism and disposition: the biological fate of chemicals 2000;28(8):973-80.
1998: Punit Marathe; DS Greene; GD Kollia; RH Barbhaiya
Evaluation of the effect of food on the pharmacokinetics of avitriptan.
Biopharmaceutics & drug disposition 1998;19(6):381-94.
1998: Nimish N Vachharajani; Wen Chyi Shyu; Theodore J Chando; Donald W Everett; DS Greene; RH Barbhaiya
Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteers.
Journal of clinical pharmacology 1998;38(8):702-7.
1998: Nimish N Vachharajani; Wen Chyi Shyu; Subbaro Mantha; J S Park; DS Greene; RH Barbhaiya
Lack of effect of food on the oral bioavailability of irbesartan in healthy male volunteers.
Journal of clinical pharmacology 1998;38(5):433-6.
1998: Theodore J Chando; Donald W Everett; A D Kahle; A M Starrett; Nimish N Vachharajani; Wen Chyi Shyu; Kishin Kripalani; RH Barbhaiya
Biotransformation of irbesartan in man.
Drug metabolism and disposition: the biological fate of chemicals 1998;26(5):408-17.
1998: Punit Marathe; DS Greene; J S Lee; RH Barbhaiya
Assessment of effect of food, gender, and intra-subject variability in the pharmacokinetics of avitriptan.
Biopharmaceutics & drug disposition 1998;19(3):153-7.
1998: Nimish N Vachharajani; Wen Chyi Shyu; Vinod R Shah; RH Barbhaiya
Pharmacokinetic assessment of the sites of first-pass metabolism of BMS-181101, an antidepressant agent, in rats.
The Journal of pharmacy and pharmacology 1998;50(3):275-8.
1998: Punit Marathe; DS Greene; GD Kollia; RH Barbhaiya
A pharmacokinetic interaction study of avitriptan and propranolol.
Clinical pharmacology and therapeutics 1998;63(3):367-78.
1998: Punit Marathe; Erik Sandefer; G E Kollia; DS Greene; RH Barbhaiya; R A Lipper; Richard C Page; WJ Doll; U Y Ryo; George A Digenis
In vivo evaluation of the absorption and gastrointestinal transit of avitriptan in fed and fasted subjects using gamma scintigraphy.
Journal of pharmacokinetics and biopharmaceutics 1998;26(1):1-20.
1997: Nimish N Vachharajani; Wen Chyi Shyu; RH Barbhaiya
Pharmacokinetic interaction between butorphanol nasal spray and oral metoclopramide in healthy women.
Journal of clinical pharmacology 1997;37(10):979-85.
1997: Punit Marathe; DS Greene; GD Kollia; RH Barbhaiya
The effects of age and gender on the single dose pharmacokinetics of avitriptan administered to healthy volunteers.
Journal of clinical pharmacology 1997;37(10):937-45.
1997: Nuggehally R Srinivas; Wen Chyi Shyu; C Gleason; A Schuster; DS Greene; RH Barbhaiya
Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects.
Clinical pharmacology and therapeutics 1997;62(4):408-16.
1997: DS Greene; RH Barbhaiya
Clinical pharmacokinetics of nefazodone.
Clinical pharmacokinetics 1997;33(4):260-75.
1997: Nuggehally R Srinivas; Wen Chyi Shyu; J Lee; DS Greene; RH Barbhaiya
Lack of effect of food on the steady state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects.
Biopharmaceutics & drug disposition 1997;18(7):585-93.
1997: Nuggehally R Srinivas; Wen Chyi Shyu; R S Weiner; G Warner; C Comereski; Lee K Tay; DS Greene; RH Barbhaiya
Assessment of dose proportionality, absolute bioavailability, and immunogenicity response of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following subcutaneous and intravenous administration to rats.
Pharmaceutical research 1997;14(7):911-6.
1997: Punit Marathe; DS Greene; RH Barbhaiya
Disposition of [14C]avitriptan in rats and humans.
Drug metabolism and disposition: the biological fate of chemicals 1997;25(7):881-8.
1997: Nimish N Vachharajani; Wen Chyi Shyu; DS Greene; RH Barbhaiya
The pharmacokinetics of butorphanol and its metabolites at steady state following nasal administration in humans.
Biopharmaceutics & drug disposition 1997;18(3):191-202.
1997: C A Knupp; RH Barbhaiya
A multiple-dose pharmacokinetic interaction study between didanosine (Videx) and ciprofloxacin (Cipro) in male subjects seropositive for HIV but asymptomatic.
Biopharmaceutics & drug disposition 1997;18(1):65-77.
1996: S Kaul; Nuggehally R Srinivas; V Mummaneni; L N Igwemezie; RH Barbhaiya
Effects of gender, age, and race on the pharmacokinetics of etoposide after intravenous administration of etoposide phosphate in cancer patients.
Seminars in oncology 1996;23(6 Suppl 13):23-9.
1996: S Kaul; Nuggehally R Srinivas; L N Igwemezie; RH Barbhaiya
A pharmacodynamic evaluation of hematologic toxicity observed with etoposide phosphate in the treatment of cancer patients.
Seminars in oncology 1996;23(6 Suppl 13):15-22.
1996: RH Barbhaiya; A B Buch; DS Greene
Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan.
British journal of clinical pharmacology 1996;42(5):573-81.
1996: C A Knupp; Lawrence J Hak; D F Coakley; R J Falk; B E Wagner; Ralph H Raasch; Charles van der Horst; S Kaul; RH Barbhaiya; G E Dukes
Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
Clinical pharmacology and therapeutics 1996;60(5):535-42.
1996: S Kaul; B Stouffer; V Mummaneni; N Turabi; S Mantha; P Jayatilak; RH Barbhaiya
Specific radioimmunoassays for the measurement of stavudine in human plasma and urine.
Journal of pharmaceutical and biomedical analysis 1996;15(2):165-74.
1996: Wen Chyi Shyu; RH Barbhaiya
Lack of pharmacokinetic interaction between butorphanol nasal spray and cimetidine.
British journal of clinical pharmacology 1996;42(4):513-7.
1996: Nimish N Vachharajani; Wen Chyi Shyu; W R Garnett; E A Morgenthien; RH Barbhaiya
The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment.
Clinical pharmacology and therapeutics 1996;60(3):283-94.
1996: V Mummaneni; S Kaul; L N Igwemezie; D R Newell; D Porter; H Thomas; A H Calvert; B Winograd; RH Barbhaiya
Bioequivalence assessment of etoposide phosphate and etoposide using pharmacodynamic and traditional pharmacokinetic parameters.
Journal of pharmacokinetics and biopharmaceutics 1996;24(4):313-25.
1996: D E Mulvana; G F Duncan; Wen Chyi Shyu; L K Tay; RH Barbhaiya
Quantitative determination of butorphanol and its metabolites in human plasma by gas chromatography-electron capture negative-ion chemical ionization mass spectrometry.
Journal of chromatography. B, Biomedical applications 1996;682(2):289-300.
1996: RH Barbhaiya
A pharmacokinetic comparison of cefadroxil and cephalexin after administration of 250, 500 and 1000 mg solution doses.
Biopharmaceutics & drug disposition 1996;17(4):319-30.
1996: Wen Chyi Shyu; E A Morgenthien; RH Barbhaiya
Pharmacokinetics of butorphanol nasal spray in patients with renal impairment.
British journal of clinical pharmacology 1996;41(5):397-402.
1996: Punit Marathe; K D Larkin; G F Duncan; DS Greene; RH Barbhaiya
Determination of a novel indolylpiperazine anti-migraine agent in rat, monkey, mouse and rabbit plasma by high-performance liquid chromatography with electrochemical detection.
Journal of chromatography. B, Biomedical applications 1996;678(2):269-77.
1996: R C Dockens; DS Greene; RH Barbhaiya
The lack effect of food on the bioavailability of nefazodone tablets.
Biopharmaceutics & drug disposition 1996;17(2):135-43.
1996: Nuggehally R Srinivas; C A Knupp; B Batteiger; R A Smith; RH Barbhaiya
A pharmacokinetic interaction study of didanosine coadministered with trimethoprim and/or sulphamethoxazole in HIV seropositive asymptomatic male patients.
British journal of clinical pharmacology 1996;41(3):207-15.
1996: Nuggehally R Srinivas; W H Barr; Wen Chyi Shyu; E Mohandoss; S Chow; J Staggers; G Balan; FJ Belas; Ian A Blair; RH Barbhaiya
Bioequivalence of two tablet formulations of nadolol using single and multiple dose data: assessment using stereospecific and nonstereospecific assays.
Journal of pharmaceutical sciences 1996;85(3):299-303.
1996: Nuggehally R Srinivas; R S Weiner; Wen Chyi Shyu; J D Calore; D Tritschler; Lee K Tay; J S Lee; DS Greene; RH Barbhaiya
A pharmacokinetic study of intravenous CTLA4Ig, a novel immunosuppressive agent, in mice.
Journal of pharmaceutical sciences 1996;85(3):296-8.
1996: R C Dockens; DS Greene; RH Barbhaiya
Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers.
Journal of clinical pharmacology 1996;36(2):160-7.
1996: RH Barbhaiya; U A Shukla; DS Greene; H P Breul; K K Midha
Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol.
Journal of clinical psychopharmacology 1996;16(1):26-34.
1996: RH Barbhaiya; A B Buch; DS Greene
A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses.
Journal of clinical psychopharmacology 1996;16(1):19-25.
1996: Nuggehally R Srinivas; R S Weiner; G Warner; Wen Chyi Shyu; T Davidson; C G Fadrowski; Lee K Tay; J S Lee; DS Greene; RH Barbhaiya
Pharmacokinetics and pharmacodynamics of CTLA4lg (BMS-188667), a novel immunosuppressive agent, in monkeys following multiple doses.
Journal of pharmaceutical sciences 1996;85(1):1-4.
1996: RH Barbhaiya; K A Dandekar; DS Greene
Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans.
Drug metabolism and disposition: the biological fate of chemicals 1996;24(1):91-5.
1996: Punit Marathe; J S Lee; DS Greene; RH Barbhaiya
Comparison of the steady-state pharmacokinetics of nefazodone after administration of 200 mg twice daily or 400 mg once daily in the morning or evening.
British journal of clinical pharmacology 1996;41(1):21-7.
1996: RH Barbhaiya; U A Shukla; P Chaikin; DS Greene; Punit Marathe
Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation.
European journal of clinical pharmacology 1996;50(1-2):101-7.
1995: DS Greene; Daniel Salazar; R C Dockens; Patricia D Kroboth; RH Barbhaiya
Coadministration of nefazodone and benzodiazepines: IV. A pharmacokinetic interaction study with lorazepam.
Journal of clinical psychopharmacology 1995;15(6):409-16.
1995: DS Greene; Daniel Salazar; R C Dockens; Patricia D Kroboth; RH Barbhaiya
Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.
Journal of clinical psychopharmacology 1995;15(6):399-408.
1995: Nuggehally R Srinivas; Wen Chyi Shyu; R S Weiner; Lee K Tay; DS Greene; RH Barbhaiya
Pharmacokinetics of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following intravenous and subcutaneous administration to mice.
Journal of pharmaceutical sciences 1995;84(12):1488-9.
1995: R C Dockens; D Rapoport; D Roberts; DS Greene; RH Barbhaiya
Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary disease.
British journal of clinical pharmacology 1995;40(6):598-601.
1995: Punit Marathe; Daniel Salazar; DS Greene; J Brennan; U A Shukla; RH Barbhaiya
Absorption and presystemic metabolism of nefazodone administered at different regions in the gastrointestinal tract of humans.
Pharmaceutical research 1995;12(11):1716-21.
1995: RH Barbhaiya; U A Shukla; Patricia D Kroboth; DS Greene
Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam.
Journal of clinical psychopharmacology 1995;15(5):320-6.
1995: Patricia D Kroboth; M M Folan; R M Lush; P C Chaikin; U A Shukla; RH Barbhaiya; Daniel Salazar
Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
Journal of clinical psychopharmacology 1995;15(5):306-19.
1995: RH Barbhaiya; Punit Marathe; DS Greene; R F Mayol; U A Shukla; R R Gammans; K A Pittman; D Robinson
Safety, tolerance, and preliminary pharmacokinetics of nefazodone after administration of single and multiple oral doses to healthy adult male volunteers: a double-blind, phase I study.
Journal of clinical pharmacology 1995;35(10):974-84.
1995: RH Barbhaiya; U A Shukla; C S Natarajan; D A Behr; DS Greene; S M Sainati
Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosis.
Clinical pharmacology and therapeutics 1995;58(4):390-8.
1995: Nuggehally R Srinivas; Wen Chyi Shyu; Vinod R Shah; D A Campbell; RH Barbhaiya
Stereoselective analysis of nadolol in human plasma.
Biomedical chromatography : BMC 1995;9(5):226-8.
1995: RH Barbhaiya; U A Shukla; DS Greene
Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans.
British journal of clinical pharmacology 1995;40(2):161-5.
1995: S Kaul; U A Shukla; RH Barbhaiya
Nonlinear pharmacokinetics of nefazodone after escalating single and multiple oral doses.
Journal of clinical pharmacology 1995;35(8):830-9.
1995: D S Thompson; A Greco; A A Miller; Nuggehally R Srinivas; K B Igwenezue; J D Hainsworth; L P Schacter; S Kaul; RH Barbhaiya; C Garrow
A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days.
Clinical pharmacology and therapeutics 1995;57(5):499-507.
1995: FJ Belas; M A Phillips; Nuggehally R Srinivas; RH Barbhaiya; Ian A Blair
Simultaneous determination of nadolol enantiomers in human plasma by high-performance liquid chromatography using fluorescence detection.
Biomedical chromatography : BMC 1995;9(3):140-5.
1995: Nuggehally R Srinivas; Wen Chyi Shyu; D Upmalis; J S Lee; RH Barbhaiya
Lack of pharmacokinetic interaction between butorphanol tartrate nasal spray and sumatriptan succinate.
Journal of clinical pharmacology 1995;35(4):432-7.
1995: Nuggehally R Srinivas; Wen Chyi Shyu; Vinod R Shah; D A Campbell; RH Barbhaiya
High-performance liquid chromatographic assay for the quantitation of nadolol in human plasma using fluorescence detection.
Biomedical chromatography : BMC 1995;9(2):75-9.
1995: S Kaul; V Mummaneni; RH Barbhaiya
Dose proportionality of stavudine in HIV seropositive asymptomatic subjects: application to bioequivalence assessment of various capsule formulations.
Biopharmaceutics & drug disposition 1995;16(2):125-36.
1995: S Z Fields; L N Igwemezie; S Kaul; L P Schacter; Russell J Schilder; P P Litam; B S Himpler; Cecilia McAleer; J Wright; RH Barbhaiya
Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(1):105-11.
1995: RH Barbhaiya; M E Brady; U A Shukla; DS Greene
Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function.
European journal of clinical pharmacology 1995;49(3):229-35.
1995: RH Barbhaiya; U A Shukla; DS Greene
Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment.
European journal of clinical pharmacology 1995;49(3):221-8.
1995: Nuggehally R Srinivas; Wen Chyi Shyu; RH Barbhaiya
Gas chromatographic determination of enantiomers as diastereomers following pre-column derivatization and applications to pharmacokinetic studies: a review.
Biomedical chromatography : BMC 1995;9(1):1-9.
1995: L N Igwemezie; S Kaul; RH Barbhaiya
Assessment of toxicokinetics and toxicodynamics following intravenous administration of etoposide phosphate in beagle dogs.
Pharmaceutical research 1995;12(1):117-23.
1994: Wen Chyi Shyu; J Haddad; J Reilly; W N Khan; D A Campbell; Y Tsai; RH Barbhaiya
Penetration of cefprozil into middle ear fluid of patients with otitis media.
Antimicrobial agents and chemotherapy 1994;38(9):2210-2.
1994: T H Grasela; Cynthia A Walawander; M Beltangady; C A Knupp; R R Martin; LM Dunkle; RH Barbhaiya; K A Pittman; Raphael Dolin; Fred Valentine
Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine.
The Journal of infectious diseases 1994;169(6):1250-5.
1994: Wen Chyi Shyu; E A Morgenthien; K A Pittman; RH Barbhaiya
The effects of age and sex on the systemic availability and pharmacokinetics of transnasal butorphanol.
European journal of clinical pharmacology 1994;47(1):57-60.
1994: RH Barbhaiya; U A Shukla; M Pfeffer; K A Pittman; R Shrotriya; C Laroudie; R E Gammans
Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses.
European journal of clinical pharmacology 1994;46(1):41-7.
1993: C A Knupp; D C Brater; J Relue; RH Barbhaiya
Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus.
Journal of clinical pharmacology 1993;33(10):912-7.
1993: C A Knupp; Wen Chyi Shyu; E A Morgenthien; J S Lee; RH Barbhaiya
Biopharmaceutics of didanosine in humans and in a model for acid-labile drugs, the pentagastrin-pretreated dog.
Pharmaceutical research 1993;10(8):1157-64.
1993: Wen Chyi Shyu; K A Pittman; D Robinson; RH Barbhaiya
Multiple-dose phase I study of transnasal butorphanol.
Clinical pharmacology and therapeutics 1993;54(1):34-41.
1993: Wen Chyi Shyu; R F Mayol; M Pfeffer; K A Pittman; R E Gammans; RH Barbhaiya
Biopharmaceutical evaluation of transnasal, sublingual, and buccal disk dosage forms of butorphanol.
Biopharmaceutics & drug disposition 1993;14(5):371-9.
1993: C A Knupp; R Milbrath; RH Barbhaiya
Effect of time of food administration on the bioavailability of didanosine from a chewable tablet formulation.
Journal of clinical pharmacology 1993;33(6):568-73.
1993: Wen Chyi Shyu; J Reilly; D A Campbell; R B Wilber; RH Barbhaiya
Penetration of cefprozil into tonsillar and adenoidal tissues.
Antimicrobial agents and chemotherapy 1993;37(5):1180-3.
1993: U A Shukla; Punit Marathe; K A Pittman; RH Barbhaiya
Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog.
Drug metabolism and disposition: the biological fate of chemicals 1993;21(3):502-7.
1993: S Kaul; Wen Chyi Shyu; U A Shukla; K A Dandekar; RH Barbhaiya
Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
Drug metabolism and disposition: the biological fate of chemicals 1993;21(3):447-53.
1993: M Beltangady; C A Knupp; N Gustafson; RH Barbhaiya; Raphael Dolin; M Seidlin; T P Cooley; M Rozencweig
Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS or AIDS-related complex.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;16 Suppl 1():S26-31.
1993: Wen Chyi Shyu; K A Pittman; D S Robinson; RH Barbhaiya
The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis.
European journal of clinical pharmacology 1993;45(6):559-62.
1993: C A Knupp; R L Milbrath; RH Barbhaiya
Effect of metoclopramide and loperamide on the pharmacokinetics of didanosine in HIV seropositive asymptomatic male and female patients.
European journal of clinical pharmacology 1993;45(5):409-13.
1992: C A Knupp; F M Graziano; R M Dixon; RH Barbhaiya
Pharmacokinetic-interaction study of didanosine and ranitidine in patients seropositive for human immunodeficiency virus.
Antimicrobial agents and chemotherapy 1992;36(10):2075-9.
1992: U A Shukla; S Kaul; Punit Marathe; K A Pittman; RH Barbhaiya
Pharmacokinetics of nefazodone following multiple escalating oral doses in the dog.
European journal of drug metabolism and pharmacokinetics 1992;17(4):309-18.
1992: U A Shukla; Punit Marathe; J A Labudde; K A Pittman; RH Barbhaiya
Pharmacokinetics of nefazodone in the dog following single oral administration.
European journal of drug metabolism and pharmacokinetics 1992;17(4):301-8.
1992: Wen Chyi Shyu; Vinod R Shah; D A Campbell; R B Wilber; K A Pittman; RH Barbhaiya
Oral absolute bioavailability and intravenous dose-proportionality of cefprozil in humans.
Journal of clinical pharmacology 1992;32(9):798-803.
1992: U A Shukla; K A Pittman; RH Barbhaiya
Pharmacokinetic interactions of cefprozil with food, propantheline, metoclopramide, and probenecid in healthy volunteers.
Journal of clinical pharmacology 1992;32(8):725-31.
1992: RH Barbhaiya; C A Knupp; M Pfeffer; D Zaccardelli; G M Dukes; W Mattern; K A Pittman; Lawrence J Hak
Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.
Antimicrobial agents and chemotherapy 1992;36(7):1387-91.
1992: RH Barbhaiya; C A Knupp; M Pfeffer; K A Pittman
Lack of pharmacokinetic interaction between cefepime and amikacin in humans.
Antimicrobial agents and chemotherapy 1992;36(7):1382-6.
1992: RH Barbhaiya; C A Knupp; K A Pittman
Effects of age and gender on pharmacokinetics of cefepime.
Antimicrobial agents and chemotherapy 1992;36(6):1181-5.
1992: J S Janiszewski; D E Mulvana; S Kaul; K A Dandekar; RH Barbhaiya
High-performance liquid chromatographic determination of 2',3'-didehydro-3'-deoxythymidine, a new anti-human immunodeficiency virus agent, in human plasma and urine.
Journal of chromatography 1992;577(1):151-6.
1992: Wen Chyi Shyu; R B Wilber; K A Pittman; RH Barbhaiya
Effect of antacid on the bioavailability of cefprozil.
Antimicrobial agents and chemotherapy 1992;36(5):962-5.
1992: Wen Chyi Shyu; Vinod R Shah; D A Campbell; J Venitz; V Jaganathan; K A Pittman; R B Wilber; RH Barbhaiya
Excretion of cefprozil into human breast milk.
Antimicrobial agents and chemotherapy 1992;36(5):938-41.
1992: RH Barbhaiya; L Wang; Wen Chyi Shyu; K A Pittman
Absolute bioavailability of cefprozil after oral administration in beagles.
Antimicrobial agents and chemotherapy 1992;36(3):687-9.
1992: RH Barbhaiya; S T Forgue; C R Gleason; C A Knupp; K A Pittman; D J Weidler; H Movahhed; J Tenney; R R Martin
Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects.
Antimicrobial agents and chemotherapy 1992;36(3):552-7.
1992: E A Papp; C A Knupp; RH Barbhaiya
High-performance liquid chromatographic assays for the quantification of amikacin in human plasma and urine.
Journal of chromatography 1992;574(1):93-9.
1991: Wen Chyi Shyu; C A Knupp; K A Pittman; LM Dunkle; RH Barbhaiya
Food-induced reduction in bioavailability of didanosine.
Clinical pharmacology and therapeutics 1991;50(5 Pt 1):503-7.
1991: Wen Chyi Shyu; U A Shukla; Vinod R Shah; E A Papp; RH Barbhaiya
Simultaneous high-performance liquid chromatographic analysis of cefprozil diastereomers in a pharmacokinetic study.
Pharmaceutical research 1991;8(8):992-6.
1991: C A Knupp; Wen Chyi Shyu; R Dolin; Fred Valentine; C McLaren; R R Martin; K A Pittman; RH Barbhaiya
Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.
Clinical pharmacology and therapeutics 1991;49(5):523-35.
1991: Wen Chyi Shyu; R B Wilber; K A Pittman; D C Garg; RH Barbhaiya
Pharmacokinetics of cefprozil in healthy subjects and patients with hepatic impairment.
Journal of clinical pharmacology 1991;31(4):372-6.
1991: Wen Chyi Shyu; K A Pittman; R B Wilber; G R Matzke; RH Barbhaiya
Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.
Journal of clinical pharmacology 1991;31(4):362-71.
1991: S Kaul; C A Knupp; K A Dandekar; K A Pittman; RH Barbhaiya
Pharmacokinetics of 2',3'-dideoxyinosine (BMY-40900), a new anti-human immunodeficiency virus agent, after administration of single intravenous doses to beagle dogs.
Antimicrobial agents and chemotherapy 1991;35(4):610-4.
1991: C J Brindley; R R Brodie; S C Cook; P R Oldfield; L F Chasseaud; RH Barbhaiya
Dose-proportional pharmacokinetics of cefepime in rats.
European journal of drug metabolism and pharmacokinetics 1991;Spec No 3():9-14.
1991: RH Barbhaiya; C A Knupp; S T Forgue; G R Matzke; C E Halstenson; J A Opsahl; K A Pittman
Disposition of the cephalosporin cefepime in normal and renally impaired subjects.
Drug metabolism and disposition: the biological fate of chemicals 1991;19(1):68-73.
1990: C A Knupp; F A Stancato; E A Papp; RH Barbhaiya
Quantitation of didanosine in human plasma and urine by high-performance liquid chromatography.
Journal of chromatography 1990;533():282-90.
1990: RH Barbhaiya; C A Knupp; J Tenney; R R Martin; D J Weidler; K A Pittman
Safety, tolerance, and pharmacokinetics of cefepime administered intramuscularly to healthy subjects.
Journal of clinical pharmacology 1990;30(10):900-10.
1990: RH Barbhaiya; C A Knupp; S T Forgue; G R Matzke; D R Guay; K A Pittman
Pharmacokinetics of cefepime in subjects with renal insufficiency.
Clinical pharmacology and therapeutics 1990;48(3):268-76.
1990: RH Barbhaiya; U A Shukla; C R Gleason; Wen Chyi Shyu; K A Pittman
Comparison of the effects of food on the pharmacokinetics of cefprozil and cefaclor.
Antimicrobial agents and chemotherapy 1990;34(6):1210-3.
1990: RH Barbhaiya; U A Shukla; C R Gleason; Wen Chyi Shyu; R B Wilber; K A Pittman
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
Antimicrobial agents and chemotherapy 1990;34(6):1204-9.
1990: RH Barbhaiya; U A Shukla; C R Gleason; Wen Chyi Shyu; R B Wilber; R R Martin; K A Pittman
Phase I study of multiple-dose cefprozil and comparison with cefaclor.
Antimicrobial agents and chemotherapy 1990;34(6):1198-203.
1990: RH Barbhaiya; S T Forgue; C R Gleason; C A Knupp; K A Pittman; D J Weidler; R R Martin
Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses.
Antimicrobial agents and chemotherapy 1990;34(6):1118-22.
1990: RH Barbhaiya; C R Gleason; Wen Chyi Shyu; R B Wilber; R R Martin; K A Pittman
Phase I study of single-dose BMY-28100, a new oral cephalosporin.
Antimicrobial agents and chemotherapy 1990;34(2):202-5.
1987: S T Forgue; Wen Chyi Shyu; C R Gleason; K A Pittman; RH Barbhaiya
Pharmacokinetics of the novel cephalosporin cefepime (BMY-28142) in rats and monkeys.
Antimicrobial agents and chemotherapy 1987;31(5):799-804.
1987: S T Forgue; K A Pittman; RH Barbhaiya
High-performance liquid chromatographic analysis of a novel carbapenem antibiotic in human plasma and urine.
Journal of chromatography 1987;414(2):343-53.
1987: RH Barbhaiya; S T Forgue; Wen Chyi Shyu; E A Papp; K A Pittman
High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine.
Antimicrobial agents and chemotherapy 1987;31(1):55-9.